<DOC>
	<DOCNO>NCT00136539</DOCNO>
	<brief_summary>The purpose study determine effectiveness safety administer Herceptin combination Taxol ( paclitaxel ) treatment woman HER2-positive , early stage breast cancer prior surgery .</brief_summary>
	<brief_title>Neoadjuvant Therapy With Herceptin Taxol Breast Cancer</brief_title>
	<detailed_description>Patients receive Herceptin intravenously weekly 12 week , Taxol intravenously every 3 week ( week 1 , week 4 , week 7 week 10 ) . After 12 week treatment , breast surgery perform ( either lumpectomy mastectomy ) . Once patient recover surgery , receive adriamycin cytoxan every 3 week 4 cycle ( 12 week total ) . After Herceptin Taxol therapy , tumor assessment perform along echocardiogram mammogram . At time surgery , re-assessment tumor do . Blood work perform day one chemotherapy cycle .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Trastuzumab</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>Patients must Stage II III histologically diagnose breast cancer Primary invasive breast cancer overexpress HER2/neu oncogene Age old 18 year Eastern Cooperative Oncology Group ( ECOG ) performance status &lt; 1 White blood cell ( WBC ) &gt; 4000/mm3 Platelet count &gt; 100,000/mm3 Bilirubin &lt; 1 x upper limit normal ( ULN ) SGOT &lt; 1 x ULN Creatinine &lt; 1.5mg/dl Normal cardiac function electrocardiogram ( EKG ) show absence ischemic change ventricular hypertrophy Excisional biopsy , sentinel node dissection axillary node dissection . Prior history breast cancer unless : diagnose least 2 year ago , present cancer previously irradiate breast , prior therapy anthracycline taxane , prior highdose chemotherapy stem cell bone marrow transplant . Pregnant breastfeed woman Uncontrolled infection Active severe cardiovascular pulmonary disease Peripheral neuropathy etiology exceeds grade 1 Prior history malignancy treat without curative intent Uncontrolled diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Early Stage Breast Cancer</keyword>
	<keyword>HER2-positive</keyword>
	<keyword>HER2-positive breast cancer</keyword>
	<keyword>Herceptin</keyword>
	<keyword>Taxol</keyword>
	<keyword>Stage II Breast Cancer</keyword>
	<keyword>Stage III Breast Cancer</keyword>
</DOC>